The Fragment-Based Drug Discovery Market is expected to grow at a 11.0 % CAGR during the forecast period for 2023-2031.
Fragment-based Drug Discovery is being used to find similar compounds like lead in drug discovery process, which is based on identification of chemical fragments, this chemical fragment may be biological target or on combining them produce a lead molecule.
Increasing novel complex medical problems creating the demand for newer fragment-based drug discovery. Moreover, as a result of increasing demand, the market for fragment-based drug discovery dominating the biopharmaceutical companies. The upsurge in technology for biophysical fragment screening is become key drivers of global fragment-based drug discovery market. Moreover, these systems providing promising access in creating chemical with similar properties like lead. Additionally, the fragment-based drug discovery systems found to be useful in marking out chemical series molecule from multiple targets, also pharmaceutical companies have increases the spending on research and development expected to create the lucrative growth in market near the future.
The Global Fragment-based Drug Discovery market is segmented on the basis of technique, service, end users and region. Based on the base technique, the market is divided into x-ray crystallography, nuclear magnetic resonance, surface plasmon resonance and other screening techniques. On the basis of service, the market is segmented into library screening, fragment screening and fragment optimization. Based on the end users, the market is divided into hospitals, industry players and non-industry players. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that Europe held the largest share of the market, followed by America and Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of forecast period.
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 11.0 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Technique, By Service, By End Users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
2bind, Charles River Laboratories, ChemAxon, ComInnex, ChemDiv, Creative Biolabs, Creative Biostructure, CRELUX, Domainex, Evotec, Red Glead Discovery, SARomics Biostructures, Shanghai ChemPartner, Sygnature Discovery, and Vernalis among others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Fragment-based Drug Discovery Market Snapshot
Chapter 4. Global Fragment-based Drug Discovery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. Technology Advancement in Fragment-based Drug Discovery Market
4.8. Key Trends in the Market
Chapter 5. Market Segmentation 1: Type of Technique Estimates & Trend Analysis
5.1. Type of Technique & Market Share, 2020 & 2028
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Type of Technique:
5.2.1. X-ray Crystallography
5.2.2. Nuclear Magnetic Resonance
5.2.3. Surface Plasmon Resonance
5.2.4. Other Screening Techniques
Chapter 6. Market Segmentation 1: Type of Service Estimates & Trend Analysis
6.1. Type of Service & Market Share, 2020 & 2028
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Type of Service:
6.2.1. Library Screening
6.2.2. Fragment Screening
6.2.3. Fragment Optimization
Chapter 7. Fragment-based Drug Discovery Market Segmentation 2: End-Users Estimates & Trend Analysis
7.1. End-Users Analysis & Market Share, 2020 & 2028
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following End-Users:
7.2.1. Industry Players
7.2.2. Non-industry Players
Chapter 8. Fragment-based Drug Discovery Market Segmentation 3: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by Type of Technique, 2020-2028
8.1.2. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by Type of Service, 2020-2028
8.1.3. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by End-Users, 2020-2028
8.1.4. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by country, 2020-2028
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, 2020-2028
8.2.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028
8.2.3. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, 2020-2028
8.2.4. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by country, 2020-2028
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, 2020-2028
8.3.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028
8.3.3. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, 2020-2028
8.3.4. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by country, 2020-2028
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, (US$ Million)
8.4.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028
8.4.3. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, (US$ Million)
8.4.4. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by country, (US$ Million) 2020-2028
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. MEA
8.5.1. MEA revenue Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, (US$ Million) 2020-2028
8.5.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028
8.5.3. MEA revenue Fragment-based Drug Discovery Market revenue (US$ Million) by country, (US$ Million) 2020-2028
8.5.3.1. South Africa
8.5.3.2. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. 2bind
9.2.2. Charles River Laboratories
9.2.3. ChemAxon
9.2.4. ComInnex
9.2.5. ChemDiv
9.2.6. Creative Biolabs
9.2.7. Creative Biostructure
9.2.8. CRELUX
9.2.9. Domainex
9.2.10. Evotec
9.2.11. Red Glead Discovery
9.2.12. SARomics Biostructures
9.2.13. Shanghai ChemPartner
9.2.14. Sygnature Discovery
9.2.15. Vernalis
9.2.16. Other Prominent Player
Global Fragment-based Drug Discovery Market Revenue (US$ Mn) by Technique
Global Fragment-based Drug Discovery Market Revenue (US$ Mn) Based on Service
Global Fragment-based Drug Discovery Market Revenue (US$ Mn) Based on End Users
Global Fragment-based Drug Discovery Market Revenue (US$ Mn) Based on Region
Europe Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country
North America Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country
Asia Pacific Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country
Latin America Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country
Middle East & Africa Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
